Impaired acylcarnitine profile in transfusion-dependent beta-thalassemia major patients in Bangladesh

[Display omitted] Patients with beta-thalassemia major (BTM) suffer from fatigue, poor physical fitness, muscle weakness, lethargy, and cardiac complications which are related to an energy crisis. Carnitine and acylcarnitine derivatives play important roles in fatty acid oxidation, and deregulation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of advanced research 2018-07, Vol.12, p.55-66
Hauptverfasser: Kumar Sarker, Suprovath, Islam, Md Tarikul, Sarower Bhuyan, Golam, Sultana, Nusrat, Begum, Mst. Noorjahan, Al Mahmud-Un-Nabi, Mohammad, Al Noman Howladar, Md. Abdulla, Farhana Dipta, Tashmim, Muraduzzaman, A.K.M., Kashfi Qadri, Syeda, Shirin, Tahmina, Sadiya, Salma, Hussain, Manzoor, Ahmed Khan, Waqar, Akhteruzzaman, Sharif, Saleheen Qadri, Syed, Qadri, Firdausi, Mannoor, Kaiissar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] Patients with beta-thalassemia major (BTM) suffer from fatigue, poor physical fitness, muscle weakness, lethargy, and cardiac complications which are related to an energy crisis. Carnitine and acylcarnitine derivatives play important roles in fatty acid oxidation, and deregulation of carnitine and acylcarnitine metabolism may lead to an energy crisis. The present study aimed to investigate carnitine and acylcarnitine metabolites to gain an insight into the pathophysiology of BTM. Dried blood spots of 45 patients with BTM and 96 age-matched healthy controls were analyzed for free carnitine and 24 acylcarnitines by using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Although medium chain acylcarnitine levels were similar in the patients with BTM and healthy controls, free carnitine, short chain acylcarnitines, long chain acylcarnitines, and total acylcarnitine levels were significantly lower in patients with BTM than in the healthy controls (P 
ISSN:2090-1232
2090-1224
DOI:10.1016/j.jare.2018.04.002